Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese Subjects
Drugs in R and D - United Kingdom
doi 10.2165/11599330-000000000-00000
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2012
Authors
Publisher
Springer Science and Business Media LLC